TPG Capital to buy iNova for $2b-plus; PEP to co-invest

Australia News News

TPG Capital to buy iNova for $2b-plus; PEP to co-invest
Australia Latest News,Australia Headlines
  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 90%

Sources say it has emerged from the auction as the most likely buyer after owners Pacific Equity Partners and The Carlyle Group took binding bids on Friday.

Private equity firm TPG Capital is set to acquire medicine and healthcare products company iNova Pharmaceuticals.Sources said TPG has agreed a deal to take a controlling stake in iNova, while existing investor Pacific Equity Partners will own a minority stake.TPG will own the lion’s share of the equity, and seek to grow the business in South East Asia and the Middle East.

iNova owns a portfolio of medicine and healthcare brands, including Difflam and Demazin, both used for cold and flu relief. Its other products include skincare label Dermaveen and weight management brand Duromine. The private equity firm’s local spearhead, Joel Thickins, is understood to be the United States as part of the fundraising.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

FinancialReview /  🏆 2. in AU

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

TPG Capital in box seat to buy iNova PharmaceuticalsTPG Capital in box seat to buy iNova PharmaceuticalsPrivate equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Read more »

TPG Capital in box seat to buy iNova PharmaceuticalsTPG Capital in box seat to buy iNova PharmaceuticalsPrivate equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Read more »

A farewell to Shiraz and Wagyu: 155,000 borrowers to feel intense painA farewell to Shiraz and Wagyu: 155,000 borrowers to feel intense painOpinion: A farewell to Shiraz and Wagyu: 155,000 borrowers to feel intense pain | Jessica Irvine
Read more »

Not much merit in Pendal acquisition: Perpetual investorNot much merit in Pendal acquisition: Perpetual investorVan Eck chief executive Arian Neiron says buying Pendal Group will not address Perpetual’s growth challenges.
Read more »

Farewell to shiraz and wagyu: 155,000 borrowers to feel intense painFarewell to shiraz and wagyu: 155,000 borrowers to feel intense painFirst home owners who bought at low interest rates will soon learn the meaning of “frugal”.
Read more »

Farewell to shiraz and wagyu: 155,000 borrowers to feel intense painFarewell to shiraz and wagyu: 155,000 borrowers to feel intense painFirst home owners who bought at low interest rates will soon learn the meaning of “frugal”. | OPINION by senior economics writer Jessica Irvine
Read more »



Render Time: 2025-04-08 07:12:44